Stay updated on Ipilimumab Nivolumab Combo in Melanoma Clinical Trial
Sign up to get notified when there's something new on the Ipilimumab Nivolumab Combo in Melanoma Clinical Trial page.

Latest updates to the Ipilimumab Nivolumab Combo in Melanoma Clinical Trial page
- ChecktodayChange DetectedRemoved related topics links for Melanoma and MedlinePlus Genetics; these are supplementary resources and do not alter the main study information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check7 days agoChange DetectedLocations section now includes New York, and the prior New York Locations listing was removed. This affects where the study is offered and where potential participants should look for site information, with the revision updated to v3.3.3.SummaryDifference0.2%

- Check15 days agoChange DetectedAdded Melanoma as a related topic and MedlinePlus Genetics as a related topic to provide disease context and access to genetics information.SummaryDifference0.2%

- Check22 days agoNo Change Detected
- Check36 days agoChange DetectedA new note explains that publications are automatically filled from PubMed, and the page revision indicates Revision: v3.3.2; the previous PubMed-related wording has been removed, and to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check43 days agoChange DetectedThe funding-status notice was removed, and melanoma-related topics including MedlinePlus Genetics links were removed.SummaryDifference0.5%

- Check50 days agoChange DetectedAdded Melanoma to the related topics section under MedlinePlus Genetics.SummaryDifference0.2%

Stay in the know with updates to Ipilimumab Nivolumab Combo in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ipilimumab Nivolumab Combo in Melanoma Clinical Trial page.